Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

Vaccine. 2001 Jul 16;19(28-29):3799-815. doi: 10.1016/s0264-410x(01)00108-6.

Authors

G François¹, M Kew, P Van Damme, M J Mphahlele, A Meheus

Affiliation

¹ WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department of Epidemiology and Social Medicine, Universiteit Antwerpen, Universiteitsplein 1, B-2610 Antwerpen, Belgium. guido.francois@uia.ua.ac.be

PMID: 11427251
DOI: 10.1016/s0264-410x(01)00108-6

No abstract available

Publication types

Review

MeSH terms

DNA-Directed DNA Polymerase / genetics
Genetic Variation
Genome, Viral
Genotype
Hepatitis B / immunology
Hepatitis B / prevention & control
Hepatitis B / virology
Hepatitis B Surface Antigens / genetics
Hepatitis B Vaccines / pharmacology
Hepatitis B e Antigens / genetics
Hepatitis B virus / classification
Hepatitis B virus / genetics*
Hepatitis B virus / immunology
Hepatitis B virus / pathogenicity
Humans
Mutation*
Promoter Regions, Genetic
Serotyping
Trans-Activators / genetics
Viral Proteins / genetics
Viral Proteins / immunology
Viral Regulatory and Accessory Proteins

Substances

Hepatitis B Surface Antigens
Hepatitis B Vaccines
Hepatitis B e Antigens
Trans-Activators
Viral Proteins
Viral Regulatory and Accessory Proteins
hepatitis B virus X protein
DNA-Directed DNA Polymerase